Article
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.
Genome medicine - 28 Aug 2025
Fergus Kirkpatrick B, Heise Rachel S, Madlensky Lisa, Fiscalini Allison, Sabacan Leah, Theiner Sarah, Kapoor Shreya, Soto Irene A, Blanco Amie, Ross Katherine, Goodman-Gruen Deborah, Scheuner Maren, Hu Donglei, Heditsian Diane, Brain Susie, Arasu Vignesh A, Kaster Andrea, Chapa Lisa, Olopade Olufunmilayo I, Eklund Martin, Tice Jeffrey A, Ziv Elad, van 't Veer Laura, Esserman Laura J, Shieh Yiwey
Abstract excerpt
BACKGROUND: The Women Informed to Screen Depending On Measures of risk (WISDOM) Study is the first prospective, population-wide application of personalized breast cancer screening. We aim to demonstrate the feasibility of the study's novel use of polygenic risk scores (PRSs) to tailor screening, evaluate our strategy for adapting PRSs to diverse populations, and quantify the impact of incorporating PRS on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
